9,762 reports of this reaction
6.5% of all DULAGLUTIDE reports
#3 most reported adverse reaction
BLOOD GLUCOSE INCREASED is the #3 most commonly reported adverse reaction for DULAGLUTIDE, manufactured by Eli Lilly and Company. There are 9,762 FDA adverse event reports linking DULAGLUTIDE to BLOOD GLUCOSE INCREASED. This represents approximately 6.5% of all 151,183 adverse event reports for this drug.
Patients taking DULAGLUTIDE who experience blood glucose increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE INCREASED is moderately reported among DULAGLUTIDE users, representing a notable but not dominant share of adverse events.
In addition to blood glucose increased, the following adverse reactions have been reported for DULAGLUTIDE:
The following drugs have also been linked to blood glucose increased in FDA adverse event reports:
BLOOD GLUCOSE INCREASED has been reported as an adverse event in 9,762 FDA reports for DULAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE INCREASED accounts for approximately 6.5% of all adverse event reports for DULAGLUTIDE, making it one of the most commonly reported side effect.
If you experience blood glucose increased while taking DULAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.